Skip to main content

IDWeek 2024 Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Live Streamed

On Demand

237 Views

A1. Novel Agents

Poster Session: Novel Agents

(P-1070) Safety and Efficacy of Replacement with Contezolid-Containing Regimens in Patients with Multidrug-Resistant/Rifampicin-Resistant Tuberculosis Who are Intolerant to Linezolid-Containing Regimens: a Retrospective Case Analysis

Friday, October 18, 2024

12:15 PM – 1:30 PM US PT

Location: Virtual

Presenting Author(s)

Tingting Chang, Associate Chief Physician (she/her/hers)

No.11,12 Martyrs' Shandong Road, Licheng District, Jinan City, Shandong Province
Department of Tuberculosis VII, Shandong Public Health Clinical Center Affiliated to Shandong University
Jinan, Shandong, China (People's Republic)

Co-Author(s)

YZ

Yuxia Zhang, Associate Chief Physician

Department of Tuberculosis VII, Shandong Public Health Clinical Center Affiliated to Shandong University
Jinan, Shandong, China
YS

Yanming Sun, Attending Physician

Department of Tuberculosis VII, Shandong Public Health Clinical Center Affiliated to Shandong University
Jinan, Shandong, China
ZZ

Zhiyuan Zhao, Attending Physician

Department of Tuberculosis VII, Shandong Public Health Clinical Center Affiliated to Shandong University
Jinan, Shandong, China
FL

Fengxia Liu, Associate Chief Physician

Department of Tuberculosis VII, Shandong Public Health Clinical Center Affiliated to Shandong University
Jinan, Shandong, China
YX

Yu Xiong, Chief Physician

Department of Tuberculosis VII, Shandong Public Health Clinical Center Affiliated to Shandong University
Jinan, Shandong, China